JPRN-UMIN000019031
Completed
未知
Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patients - Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patients
Haga Diabetes Clinic0 sites40 target enrollmentSeptember 16, 2015
ConditionsType 2 diabetes mellitus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 diabetes mellitus
- Sponsor
- Haga Diabetes Clinic
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Type 1 diabetic patients. Patients with a history of severe ketosis or diabetic coma in previous 6 months. Patients with severe infection, before/after surgery or severe traumatic injury. Patients to have a plan to be pregnant. Patients with severe gastroenteric disturbance as exemplified by severe gastro\-paresis. Patients with a history of pancreatitis.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy and safety of dulaglutide when used instead of sitagliptin in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000023245Iwasaki Naika Clinic40
Recruiting
Not Applicable
Efficacy and safety of dulaglutide in the treatment of type 2 diabetesType 2 diabetes mellitus patientsJPRN-UMIN000027255Department of nephrology, Matsunami general hospital30
Completed
Not Applicable
Safety and efficacy of dulaglutide therapy for the inpatient management of general medicine patients with type 2 diabetesType 2 diabetesJPRN-UMIN000025006Ichinomiyanishi hospital40
Unknown
Not Applicable
Comparison of the efficacy and safety of dulaglutide in combination with insulin compared with insulin alone in daibetes patients who are receiving high dose glucocorticoids therapy: a randomized,open-label trialDiabetes mellitusJPRN-UMIN000020037Kanagawa Cardiovascular and Respiratory Center30
Completed
Not Applicable
Efficacy of dulaglutide after switching from incretin related drugs in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000042812Edogawa Hospital101